Navigation Links
CORD:USE Cord Blood Bank Announces the Addition of Dr. John Wagner, a Pioneer in the Use of Umbilical Cord Blood Stem Cells, to Its Scientific Advisory Board
Date:1/30/2008

ORLANDO, Fla., Jan. 30 /PRNewswire/ -- John Wagner, M.D., recognized as a leader in the field of cord blood stem cell transplantation, has joined the team at CORD:USE Cord Blood Bank. Dr. Wagner's extensive experience and knowledge in transplant medicine and stem cell biology will provide a significant contribution to CORD:USE.

"We're honored and fortunate to have him as a member of our distinguished team," says Edward Guindi, M.D., President and CEO of CORD:USE Cord Blood Bank.

Dr. Wagner is internationally recognized as an expert in the field of stem cells and use of unrelated hematopoietic stem cell transplant. He is a professor of Pediatrics and the Director of the Division of Hematology- Oncology and Blood and Marrow Transplantation at the University of Minnesota. He is also the Scientific Director of Clinical Research of the Stem Cell Institute and Director of the Center of Molecular and Cellular Therapeutics.

Dr. Wagner has played a considerable role in the development and expansion of the applications of cord blood stem cells. His investigations on the simultaneous use of two cord blood units for transplantation in adults has made it possible for nearly all patients to benefit from cord blood stem cell transplantation who otherwise would not have been candidates for this therapy.

"Without question, I look forward to working with such a distinguished board of scientific advisors and the impressive team at CORD:USE," says Dr. Wagner. "Cord blood stem cells have already played an extremely important role in the treatment of thousands of patients, and I foresee the uses of cord blood expanding, such as in the field of regenerative medicine and tissue repair. The experience and expertise of the team at CORD:USE will help ensure that CORD:USE remains a leader in the field."

Dr. Wagner joins other highly-respected leaders in the field of cord blood stem cell transplantation at CORD:USE. Dr. Joanne Kurtzberg is the Director of the Pediatric Blood and Marrow Program at Duke University and the Medical Director of the CORD:USE Cord Blood Bank at Duke. She performed the first transplantation using an unrelated donor's stem cells and has since performed over 800 umbilical cord blood transplants.

Dr. Wagner also joins Dr. Hal Broxmeyer, a founder of the field of cord blood stem cell transplantation and widely recognized as one of the foremost experts in the world in cord blood stem cell science. Also on the CORD:USE team is Dr. Alan Levine, who serves as the company's Chief Scientific Officer. Dr. Levine enjoyed a highly successful 25-year career with the National Institutes of Health ("NIH") where he was most recently the Director of the Blood Disease Program of the National Heart, Lung, and Blood Institute of the NIH. In this capacity, Dr. Levine was responsible for initiating the bone marrow and umbilical cord blood research programs at the NIH.

Dr. Levine works closely with CORD:USE team member Dr. Esmail Zanjani, a world-renowned expert in blood stem cell biology who has led the development of the field of in utero stem cell transplantation and gene therapy as a means for curing genetic diseases prior to birth.

About CORD:USE Cord Blood Bank, Inc.

CORD:USE Cord Blood Bank, headquartered in Orlando, Florida, is creating a large, ethnically diverse, high quality inventory of available cord blood stem cell units for the many patients in need of a potentially life-saving transplant. Cord blood stem cells have been used successfully in the treatment of over 70 blood cancers and diseases. CORD:USE Cord Blood Bank has entered into agreements with hospitals across the country to provide mothers the option to donate their babies' cord blood. CORD:USE distributes cord blood units to transplanters, throughout the country and the world, as a critical component in their patients' treatment. CORD:USE lists all of its units on the National Marrow Donor Program's Registry. For more information, please visit our Web site http://www.corduse.com or contact Michael Ernst at 407-667- 4844 or by e-mail at mernst@corduse.com.


'/>"/>
SOURCE CORD:USE Cord Blood Bank, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
2. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
3. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
4. The International Diabetes Federation (IDF) Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes
5. CDC Awards NATT Funding to Improve Blood Clot Awareness
6. FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels
7. Cellestis Receives FDA Approval for Blood Test for Detecting Tuberculosis
8. Blood Donations in U.S. Testing Positive for Chagas Disease
9. One of Nations Oldest Blood Services Providers Turns to Sysmex America
10. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
11. AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... , June 23, 2016 A person commits ... the crime scene to track the criminal down. ... U.S. Food and Drug Administration (FDA) uses DNA evidence to ... Sound far-fetched? It,s not. The FDA has ... to support investigations of foodborne illnesses. Put as simply as ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
Breaking Biology Technology:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
Breaking Biology News(10 mins):